NCT03722524
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension
See it on ClinicalTrials.gov ↗1,148 people
60.4%
39.6%
687 womenmiddle line = equal numbers451 men
- Phase
- —
- Paid for by
- Servier Russia
- Finished
- 2019-07-17
- Health conditions
- Arterial Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 59.24 years
- Age 65+
- 29.4%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported 100% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · Black / African American 0% · White 0% · More than one race 0%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Diseases with severe organ dysfunction (hepatic failure, renal failure, etc.)”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of myocardial infarction, unstable angina, or cerebrovascular accident within the past 1 year”
- No diabetes
Women with diabetes were turned away.
“Type I diabetes or decompensated type 2 diabetes”
Study titles and rules are shown in their original English.